Validez de las pruebas utilizadas en el diagnóstico inicial y su concordancia con el diagnóstico final en pacientes con sospecha de hiperplasia benigna de próstata

Abstract

Concordance between BPH initial diagnosis based on MH+I-PSS+DRE+PSA and diagnosis based on a full range of tests was high, thus allowing recommending the use of this group of initial diagnostic procedures, which are available to the primary care physician, not only as a first diagnostic step in patients with suspected BPH, but also as a valid strategy to prevent unnecessary delay in its initial management and to facilitate appropriate referral from primary to specialized care.

Involvement of Fibroblast Growth Factor Receptor Genes in Benign Prostate Hyperplasia in a Korean Population

“…Clinical study demonstrated that men with prostate volume ≥ 31 mL, PSA ≥ 1.6 ng/mL, or Q max⁡⁡ < 10.6 mL/sec at baseline had a significantly increased risk of overall clinical progression of BPH [29]. Although IPSS and PSA are simple BPH diagnostic factors used in the primary care setting, a previous study showed a high correlation between BPH diagnosed by simple tests (medical history, IPSS, digital rectal examination (DRE), and PSA) and that diagnosed by a full battery of tests including ultrasonographic assessment of residual and prostatic volume, and uroflowmetry [30]. Thus, these factors may also be useful as predictors of BPH progression.…”